Pharmacy Diversion Awareness Conference
November 16 & 17, 2013; Louisville Marriott Downtown; Louisville, Kentucky
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on November 16th & 17th, 2013 in Louisville, Kentucky. This was a one-day conference, repeated on the second day, for the convenience of the pharmacy community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 145 pharmacists, pharmacy technicians, and loss prevention personnel attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included: Drug Trends; Drugs, Drugs, and More Drugs; Kentucky Board of Pharmacy Update; KASPER-Challenges and Legislative Changes in Kentucky; Pharmaceutical Diversion in Medicare; CMEA Requirements for Retail Distributors; and Drug Theft Prevention.
Select presentations from the PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure, are below.
Drug Trends – Alan G. Santos, Associate Deputy Assistant Administrator, DEA Office of Diversion Control
Drugs, Drugs, and More Drugs – Presented for William Winsley by Michael Burleson, R.Ph., Executive Director, Kentucky Board of Pharmacy
Kentucky Board of Pharmacy Update – Michael Burleson, R.Ph., Executive Director, Kentucky Board of Pharmacy
KASPER – Challenges and Legislative Changes in Kentucky – Amanda J. Ward, Pharm.D, R.Ph., CGP, Pharmacist Consultant, Kentucky Office of Inspector General, Division of Audits & Investigations, Drug Enforcement and Professional Practices Branch
Pharmaceutical Diversion in Medicare – Tyler Smith, Assistant Inspector General for Investigations, OIG/HHS
CMEA Requirements for Retail Distributors – Tom Prevoznik, Staff Coordinator, DEA Liaison & Policy Section, DEA Office of Diversion Control